Is FH.NE stock a buy after the drop?

FH.NE stock is speculative after the fall to **C$0.01**. Traders seeking an oversold bounce may enter small positions above **C$0.015** with tight stops. Long-term buyers should wait for revenue growth and liquidity improvement.

What are sensible price targets for FH.NE stock?

A tactical bounce target is **C$0.03** and a longer 12-month scenario is **C$0.05**. These targets come from pattern recovery and model scenarios. All targets are projections, not guarantees.

How does the Meyka grade affect FH.NE stock outlook?

Meyka AI rates FH.NE with a score out of 100: **57.72**, Grade **C+** and suggestion **HOLD**. The grade balances sector and financial metrics and flags the stock as speculative for tactical trades.

What risks should traders watch for with FH.NE stock?

Main risks: low liquidity, weak current ratio **0.44**, high price volatility, and limited revenue. News around R&D or financing can move the stock sharply. Use stops and small position sizes.

CA Stocks

FH.NE Filament Health (NEO) C$0.01 in market hours: Oversold bounce setup

ByHuzaifa Zahoor January 21, 2026January 21, 2026

Filament Health Corp. (FH.NE) trades at C$0.01 in market hours on 21 Jan 2026, marking a one-day drop of -33.33%. The sharp move leaves FH.NE stock deeply oversold versus its 50-day average of C$0.02 and 200-day average of C$0.03. Volume at 929,483 shares signals active selling but also creates a clearing condition for a short-term bounce. We outline a tactical oversold bounce strategy for traders on the NEO exchange in Canada, tying technical levels to fundamentals, price targets, and risk controls.